Stocks · Health care · Surgical & Medical Instruments & Apparatus

TriSalus Life Sciences, Inc.

TLSI Clue Score59
United States Fiscal year ends December CIK 0001826667 Results filed 6 Aug 2026

What the insiders did Net buying

By person

18 insiders · 30 transactions
7.8×

Mary Szela holds 7.8 times base salary in stock. $4.72M of shares against $600.92K in salary for 2025.

Salary from the company's own proxy. The shares are what Mary Szela last reported holding, valued at $4.39, the price Common Stock was last bought or sold at on the open market here, on 5 Oct 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Michael P Stansky
Director
$3.01M (4)
—
+$3.01M
1,640,420
2.66%
$7.20M
+162.2%
Mats Wahlstrom
Director
$151.80K (1)
—
+$151.80K
147,555
0.2396%
$647.77K
—
Mary T Szela
CEO and President
$227.77K (2)
$79.38K (2)
+$148.39K
1,074,990
1.75%
$4.72M
+107.5%
William Valle
Director
$125.00K (1)
—
+$125.00K
83,241
0.1352%
$365.43K
—
Gary B. Gordon
Director
$64.60K (2)
—
+$64.60K
72,510
0.1178%
$318.32K
—
David Patience
Chief Financial Officer
$32.25K (2)
—
+$32.25K
261,107
0.4240%
$1.15M
—
Richard Marshak
Chief Commercial Officer
—
$17.09K (5)
−$17.09K
127,994
0.2079%
$561.89K
+328.0%
Jennifer Stevens
Chief Regulatory Officer
—
$15.90K (4)
−$15.90K
123,794
0.2010%
$543.46K
+277.6%
Bryan F. Cox
Chief of Research
—
$14.38K (4)
−$14.38K
162,805
0.2644%
$714.71K
+74.6%
Jodi Devlin
Chief of Clinical Operations
—
$13.17K (3)
−$13.17K
97,364
0.1581%
$427.43K
+536.1%
Equity AB Frankenius
10% owner
—
—
—
6,989,748
11.35%
$30.68M
+13.3%
David J Matlin
Director
—
—
—
1,323,210
2.15%
$5.81M
+42.0%
Kerry R Hicks
Director
—
—
—
542,790
0.8815%
$2.38M
+5.5%
Sean Murphy
Director
—
—
—
321,721
0.5225%
$1.41M
+47.2%
Arjun JJ Desai
Director
—
—
—
247,127
0.4013%
$1.08M
−10.8%
Richard Henry Marshall
Chief Medical Officer
—
—
—
90,000
0.1462%
$395.10K
+200.0%
James Emmett Young
Chief Financial Officer
—
—
—
79,663
0.1294%
$349.72K
+763.5%
Liselotte Hyveled
Director
—
—
—
10,040
0.0163%
$44.08K
—